만성 창상 관리 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global chronic wound care market size is expected to reach USD 26.20 Billion in 2034 from USD 17.74 Billion in 2025, growing at a CAGR of 4.43 during 2026-2034.The Global Chronic Wound Care Market is witnessing strong growth due to the increasing prevalence of chronic wounds such as diabetic ulcers, pressure ulcers, and venous leg ulcers. These wounds require specialized care and advanced treatment solutions to promote healing and prevent complications. The rising incidence of diabetes and aging populations worldwide are major factors contributing to the growing demand for chronic wound care products.

Advancements in wound care technologies are transforming the treatment landscape. Innovative products such as advanced dressings, negative pressure wound therapy systems, and bioengineered skin substitutes are improving healing outcomes and reducing treatment time. Healthcare providers are increasingly adopting modern wound care solutions to manage complex wounds more effectively.

Looking ahead, the Global Chronic Wound Care Market is expected to grow due to increasing investments in wound management research and healthcare infrastructure. Companies are focusing on developing more efficient and cost-effective wound care products to meet the growing demand. As awareness about chronic wound management continues to rise and healthcare systems prioritize advanced treatment solutions, the market is projected to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• Diabetic Ulcers
• Pressure Ulcers
• Venous Leg Ulcers
• Others

By Product

• Advanced Wound Dressings
• Wound Care Devices
• Active Therapy
• Others

By End User

• Hospitals & Wound Clinics
• Homecare Settings & Others

COMPANIES PROFILED

• 3M Company, AdvaCare Pharma, B. Braun Melsungen AG, Baxter International Inc., Cardinal Health, Inc., Coloplast Corp., ConvaTec Group plc, Essity AB (BSN Medical), Integra LifeSciences Corporation (Derma Sciences), Johnson & Johnson, Medline Industries, Inc., MiMedx Group, Inc., Molnlycke Health Care AB, PAUL HARTMANN AG, Smith & Nephew plc, Tissue Regenix Group plc

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CHRONIC WOUND CARE MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Diabetic Ulcers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Pressure Ulcers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Venous Leg Ulcers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CHRONIC WOUND CARE MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Advanced Wound Dressings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Wound Care Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Active Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CHRONIC WOUND CARE MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals & Wound Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Homecare Settings & Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CHRONIC WOUND CARE MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Product
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Product
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Product
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Product
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Product
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CHRONIC WOUND CARE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 3M Company
  • 9.2.2 AdvaCare Pharma
  • 9.2.3 B. Braun Melsungen AG
  • 9.2.4 Baxter International Inc
  • 9.2.5 Cardinal HealthInc
  • 9.2.6 Coloplast Corp
  • 9.2.7 ConvaTec Group Plc
  • 9.2.8 Essity AB (BSN Medical)
  • 9.2.9 Integra LifeSciences Corporation (Derma Sciences)
  • 9.2.10 Johnson & Johnson
  • 9.2.11 Medline IndustriesInc
  • 9.2.12 MiMedx GroupInc
  • 9.2.13 Molnlycke Health Care AB
  • 9.2.14 PAUL HARTMANN AG
  • 9.2.15 Smith & Nephew Plc
  • 9.2.16 Tissue Regenix Group Plc